Page 45 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 45

CHAPTER 2  Drug Receptors & Pharmacodynamics     31


                    TABLE 2–1  G proteins and their receptors and effectors.

                     G Protein   Receptors for                                   Effector/Signaling Pathway
                                 β-Adrenergic amines, histamine, serotonin, glucagon, and many   ↑ Adenylyl cyclase →↑ cAMP
                     G s
                                 other hormones
                     G i1 , G i2 , G i3  α 2 -Adrenergic amines, acetylcholine (muscarinic), opioids,    Several, including:
                                 serotonin, and many others                       ↓ Adenylyl cyclase →↓ cAMP
                                                                                             +
                                                                                   Open cardiac K  channels →↓ heart rate
                                 Odorants (olfactory epithelium)                 ↑ Adenylyl cyclase →↑ cAMP
                     G olf
                                 Neurotransmitters in brain (not yet specifically identified)  Not yet clear
                     G o
                     G q         Acetylcholine (muscarinic), bombesin, serotonin (5-HT 2 ), and    ↑ Phospholipase C →↑ IP 3 , diacylglycerol, cytoplasmic Ca 2+
                                 many others
                     G t1 , G t2  Photons (rhodopsin and color opsins in retinal rod and    ↑ cGMP phosphodiesterase →↓ cGMP (phototransduction)
                                 cone cells)
                    cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; IP3, inositol-1,4,5-trisphosphate.



                    of G proteins. The apparent promiscuity of such a ligand allows   both proteins, allowing agonist binding to the receptor to effec-
                    it to elicit different G protein-dependent responses in different   tively “drive” a nucleotide exchange reaction that “switches” the
                    cells. For instance, the body responds to danger by using catechol-  G protein from its inactive (GDP-bound) to active (GTP-bound)
                    amines (norepinephrine and epinephrine) both to increase heart   form. Figure 2–11 shows the main components schematically.
                    rate and to induce constriction of blood vessels in the skin, by
                    acting on G -coupled β adrenoceptors and G -coupled α  adreno-
                             s
                                                      q
                                                               1
                    ceptors, respectively. Ligand promiscuity also offers opportunities
                    in drug development (see Receptor Classes & Drug Development               Agonist
                    in the following text).
                       Receptors that signal  via G  proteins are  often  called  “G   Outside
                    protein-coupled receptors” (GPCRs). GPCRs make up the largest     N
                    receptor family and are also called “seven-transmembrane” (7TM)              II
                    or “serpentine” receptors because the receptor polypeptide chain           I
                    “snakes” across the plasma membrane seven times (Figure 2–11).                   III
                    Receptors for adrenergic amines, serotonin, acetylcholine (musca-     VII  Ag   IV
                    rinic but not nicotinic), many peptide hormones, odorants, and           VI   V
                    even visual receptors (in retinal rod and cone cells) all belong to
                    the GPCR family. All were derived from a common evolutionary   Inside      C
                    precursor. A few GPCRs (eg, GABA  and metabotropic glutamate   HO                     G
                                               B
                    receptors) require stable assembly into homodimers (complexes of            OH      protein
                    two identical receptor polypeptides) or heterodimers (complexes of   OH  OH
                    different isoforms) for functional activity. However, in contrast to   FIGURE 2–11  Transmembrane topology of a typical “serpen-
                    tyrosine kinase and cytokine receptors, dimerization is not univer-  tine” GPCR. The receptor’s amino (N) terminal is extracellular (above
                    sally required for GPCR activation, and many GPCRs are thought   the plane of the membrane), and its carboxyl (C) terminal intracellu-
                    to function as monomers.                             lar, with the polypeptide chain “snaking” across the membrane seven
                       GPCRs can bind agonists in a variety of ways, but they all   times. The hydrophobic transmembrane segments (light color) are
                    appear to transduce signals across the plasma membrane in a simi-  designated by Roman numerals (I–VII). Agonist (Ag) approaches the
                    lar way. Agonist binding (eg, a catecholamine or acetylcholine)   receptor from the extracellular fluid and binds to a site surrounded
                    stabilizes a conformational state of the receptor in which the cyto-  by the transmembrane regions of the receptor protein. G protein
                    plasmic ends of the transmembrane helices spread apart by about   interacts with cytoplasmic regions of the receptor, especially around
                    1 nm, opening a cavity in the receptor’s cytoplasmic surface that   the third cytoplasmic loop connecting transmembrane regions V and
                    binds a critical regulatory surface of the G protein. This reduces   VI. Lateral movement of these helices during activation exposes an
                    nucleotide affinity for the G protein, allowing GDP to dissociate   otherwise buried cytoplasmic surface of the receptor that promotes
                                                                         guanine nucleotide exchange on the G protein and thereby activates
                    and GTP to replace it (this occurs because GTP is normally pres-  the G protein, as discussed in the text. The receptor’s cytoplasmic
                    ent in the cytoplasm at much higher concentration than GDP).   terminal tail contains numerous serine and threonine residues whose
                    The GTP-bound form of G protein then dissociates from the   hydroxyl (-OH) groups can be phosphorylated. This phosphorylation
                    receptor and can engage downstream mediators. Thus GPCR–G   is associated with diminished receptor-G protein coupling and can
                    protein coupling involves coordinated conformational change in   promote receptor endocytosis.
   40   41   42   43   44   45   46   47   48   49   50